[1] | Kuo, K.L., Weng, M.S., Chiang, C.T., Tsai, Y.J., Lin-Shiau, S.Y. and Lin, J.K, “Comparative studies on the hypolipidemic and growth suppressive effects of oolong, black, pu-erh, and green tea leaves in rats,” J Agric Food Chem, 2: 480-489. 2005. |
|
[2] | Zhou, H.J., Gong, J.S., Wang, X.Y., Mi, M. and Yang, K, Yunnan Pu-erh Tea, Kunming, Yunnan Science and Technology Press, 2004. |
|
[3] | Zhao, X., Qian, Y., Zhou, Y.L., Wang, R., Wang, Q. and Li, G.J, “Pu-erh tea has in vitro anticancer activity in TCA8113 cells and preventive effects on buccal mucosa cancer in U14 cells injected mice in vivo,” Nutr Cancer, 66(6): 1059-69. 2014. |
|
[4] | Zheng, X.N., Wang, X.W., Li, L.Y., Xu, Z.W,, Huang, H.Y., Zhao, J.S., Zhang, D., Yin, X., Sheng, J. and Tang, J.T, “Pu-erh tea powder preventive effects on cisplatin-induced liver oxidative damage in Wistar rats,” Asian Pac J Cancer Prev, 15(17): 7389-94. 2014. |
|
[5] | Shimamura, Y., Yoda,M., Sakakibara, H., Matsunaga, K. and Masuda, S, “Pu-erh tea suppresses diet-induced body fat accumulation in C57BL/6J mice by down-regulating SREBP-1c and related molecules,” Biosci Biotechnol Biochem, 77(7): 1455-60. 2013. |
|
[6] | Wu, C.W., Yen, C.Y., Wang, B.S., Chiu, C.K., Yen, W.J., Chang, L.W. and Duh, P.D, “Antimutagenic and antimicrobial activities of pu-erh tea,” Food Sci Techno, 3: 506–512. 2007. |
|
[7] | Zhou, H.J., Mi, M., Han, J., Li, J.H. and Ai, T, “The effective mechanism advancement of the pu-erh tea,” Cha Ye, 29: 75-779. 2003. |
|
[8] | Grundy, S.M, “Metabolic syndrome: a multiplex cardiovascular risk factor,” J Clin Endocrinol Metab, 2: 399-404. 2007. |
|
[9] | Kahn, S,E. and Hull, R.L, “Utzschneider KM, Mechanisms linking obesity to insulin resistance and type 2 diabetes,” Nature, 7121: 840-846. 2006. |
|
[10] | Rutter, M.K., Meigs, J.B., Sullivan, L.M., D'Agostino, R.B. and Wilson, P.W, “Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham offspring study,” Diabetes, 11: 3252-3257. 2005. |
|
[11] | Zhu, Q., Clifford, M.N., Mao, Q.L., Deng, F.M, “Comparative Study on the Components of Pu’er Tea and Fu-Brick Tea with Black Tea by LC-MS,” J Tea Sci, 26(3): 191-194.2006. |
|
[12] | Yang, X.H., Wang, L.L., Huang, J.A., Wu, W.L. and Liu, Z.H, “Preliminary Study on Fractions and Correlative properties of Theabrownin from Pu-erh Tea,” J Tea Sci, 3:187-194. 2011. |
|
[13] | Zhong, L, Physicochemical analysis of tea quality, Shanghai, Shanghai science and technology press, 1989. |
|
[14] | Yao, Y.J, Study on extraction, isolation, purification, structure identification and immune activity of polysaccharide from fruiting body of Coprinus comatus (Mull.:Fr.) Gray, Nanjing Agricultural University, 2007. |
|
[15] | Yuan, Y.S., Zhu, W.H. and Chen, J.H, Biochemical experiment, Beijing, higher education press, 1998. |
|
[16] | Wang, K.B., Liu, Z.H. and Huang, J.A, “Studies on preparing theaflavins from oxidation of tea catechins in vitro,” J Tea Sci, 1: 53-59. 2004. |
|
[17] | James, W.P., Rigby, N. and Leach, R, “Obesity and the metabolic syndrome: the stress on society,” Ann N Y Acad Sci, 1083: 1-10. 2006. |
|
[18] | Feve, B, “Adipogenesis: cellular and molecular aspects,” Best Pract Res Clin Endocrinol Metab, 4: 483-499. 2005. |
|
[19] | Bluher, S., Kratzsch, J. and KIess, W, “Insulin-like growth factor l, growth hormone and insulin in white adipose tissue,” Best Pract Res Clin Endocrinol Metab, 4: 577-587. 2005. |
|
[20] | Song, L.B, Study on Pharmacological Function Evaluation and Active Substances of Chinese Dark Tea, Hunan Agricultural University, 2008. |
|
[21] | Sun, L.X. and Liu, Z.H.Q, “Resisting Arteriosclerosis of Pu-erh Tea, Chinese tea International Academic Aymposium on Chinese Pu-erh Tea in 2002,” Yunnan People’s Publishing House. 309-317. 2002. |
|
[22] | Jie, G.L, Study on Antioxidation and Reducing Weight of Pu-erh Tea, Zhejiang University, 2008. |
|
[23] | Wang,Q.P., Peng, C.X., Gao, B. and Gong, J.S, “Influence of large molecular polymeric pigments isolated from fermented Zijuan tea on the activity of key enzymes involved in lipid metabolism in rat,” Experimental gerontology (Exp Gerontol), 9: 672-679.2012. |
|
[24] | Mingrone, G., Rosa, G., Rocco, P.D., Manco, M., Capristo, E., Castagneto, M., Vettor, R., Gasbarrini, G. and Greco, A.V, “Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-α reduction and GLUT4 expression enhancement,” Int J Obes Relat Metab Disord, 9: 1165-1172. 2002. |
|
[25] | MacLean, P.S., Zheng, D., Jones, J.P., Olson, A.L. and Dohm, G.L, “Exercise-induced transcription of the muscle glucose transporter (GLUT4) gene,” Biochem Biophys Res Commun, 2: 409-414. 2002. |
|
[26] | Ducluzeau, P.H., Perretti, N., Laville, M., Andreelli, F., Vega, N., Riou. J.P. and Vidal, H, “Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue. Evidence for Specific Defects in Type 2 Diabetes,” Diabetes, 5: 1134-1142. 2001. |
|
[27] | Pessler, D., Rudich, A. and Bashan, N, “Oxidative stress impairs nuclear proteins binding to the insulin responsive element in the GLUT4 promoter,” Diabetologia, 12: 2156-2164. 2001. |
|
[28] | Perrini, S., Natalicchio, A., Laviola, L., Belsant,i G., Montrone, C., Cignarelli, A., Minielli, V., Grano, M., De Pergola, G., Giorgino, R. and Giorgino, F, “Dehydroepiandrosterone Stimulates Glucose Uptake in Human and Murine Adipocytes by Inducing GLUT1 and GLUT4 Translocation to the Plasma Membrane,” Diabetes, 1: 41-52. 2004. |
|
[29] | George, S., Rochford, J.J., Wolfrum, C., Gray, S.L., Schinner, S., Wilson, J.C., Soos, M.A., Murgatroyd, P.R., Williams, R.M., Acerini, C.L., Dunger, D.B., Barford, D., Umpleby, A.M., Wareham, N.J., Davies, H.A., Schafer, A.J., Stoffel, M., O'Rahilly, S. and Barroso, I, “A family with severe insulin resistance and diabetes due to a mutation in AKT2,” Science, 5675: 1325-1328. 2004. |
|
[30] | Sano, H., Kane, S., Sano, E., Mîinea, C.P., Asara, J.M., Lane, W.S., Garner, C.W. and Lienhard, G.E, “Insulin-stimulated phosphorylation of a rab GTPase-activating protein regulates GLUT4 translocation,” J Biol Chem, 17: 14599-14602. 2003. |
|
[31] | Taghibiglou, C., Rashid-Kolvear, F., Van Iderstine, S.C., Le-Tien, H., Fantus, I.G., Lewis, G.F.and Adeli, K, “Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyorsine phosphatase 1B in a fructose-fed hamster mode of insulin resistance,” J Biol Chem, 1: 793-803. 2002. |
|
[32] | Hirata, A.E., Alvarez-Rojas, F., Carvalheira, J.B. and Carvalho, C.R, “Dolnikoff MS and Abdalla Saad MJ, Modulation of IR /PTP1B interaction and downstream signaling in insulin sensitive tissues of MSG–rats,” Life Sci,11: 1369-1381. 2003. |
|
[33] | Gum, R.J., Gaede, L.L., Koterski, S.L., Heindel, M., Clampit, J.E., Zinker, B.A., Trevillyan, J.M., Ulrich, R.G., Jirousek, M.R. and Rondinone, C.M, “Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob,” Diabetes, 1: 21-28. 2003. |
|
[34] | Goldstein, B.J., Bittner-Kowalczyk, A., White, M.F. and Harbeck, M, “Tyorsine dephosphorylation and deactivation of insulin receptor substrate-1 by portein-tyorsine phosphatase 1B.Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein,” J Biol Chem, 6: 4283-4289. 2000. |
|
[35] | Chiang, C.T., Weng, M.S., Lin-Shiau, S.Y., Kuo, K.L., Tsai, Y.J. and Lin, J.K., “Pu-erh Tea Supplementation Suppresses Fatty Acid Synthase Expression in the Rat Liver Through Downregulating Akt and JNK Signalings as Demonstrated in Human Hepatoma HepG2 Cells,” Oncology Research, 3:119-128. 2006. |
|
[36] | Way, T.D., Lin, H.Y., Kuo, D.H., Tsai, S.J., Shieh, J.C., Wu, J.C., Lee, M.R. and Lin, J.K, “Pu-erh Tea Attenuates Hyperlipogenesis and Induces Hepatoma Cells Growth Arrest through Activating AMP-Activated Protein Kinase (AMPK) in Human HepG2 Cells,” J Agric Food Chem, 12: 5257-5264. 2009. |
|